To assess whether TCF19 silencing compromises also the proliferation potential of prostate cancer cell lines, we generated stable shRNA expressing PC3, DU145, LnCaP, C4‐2, and 22Rv1 cells. This evidence concerns the gene TCF19 and prostate carcinoma.